Fundsmith LLP Terry Smith
London, X0 20 processed 13Fs on this site, 2021 Q3 to 2026 Q2
- $13.6B
- 41 holdings
- 2026 Q2
- +6.4% QoQ
- Top 5 29.8%
Terry Smith's biggest moves in 2026 Q2 were opening Uber and Mastercard, adding to Napco Sec Technologies and Manhattan Associates, trimming Philip Morris International and Idexx Laboratories, and selling out of Mettler-Toledo and Zoetis.
AUM over time
Latest book
| MAR, Marriott | Reduce −23.3% | 2,585,757 | $370.59 | $958M | −785,115 | −$144M | |
| SYK, Stryker | Reduce −4.8% | 2,913,833 | $314.84 | $917M | −147,583 | −$89M | |
| WAT, Waters | Reduce −29.2% | 2,273,632 | $375.04 | $853M | −938,443 | −$104M | |
| V, Visa | Reduce −34.9% | 2,019,810 | $343.09 | $693M | −1,084,280 | −$245M | |
| UBER, Uber | New | 8,943,151 | $72.16 | $645M | +8,943,151 | +$645M | |
| MA, Mastercard | New | 1,245,051 | $513.60 | $639M | +1,245,051 | +$639M | |
| GOOGL, Alphabet | Reduce −40.0% | 1,773,354 | $357.37 | $634M | −1,182,844 | −$216M | |
| CHD, Church & Dwight | Reduce −2.8% | 6,456,634 | $96.88 | $626M | −184,874 | +$5.7M | |
| PG, Procter & Gamble | Reduce −2.9% | 4,078,371 | $146.64 | $598M | −121,543 | −$8.6M | |
| MSFT, Microsoft | Reduce −23.2% | 1,596,737 | $373.02 | $596M | −483,000 | −$174M | |
| META, Meta Platforms | Reduce −20.4% | 1,051,876 | $563.29 | $593M | −269,499 | −$163M | |
| ADP, Automatic Data Processing | Reduce −32.5% | 2,601,567 | $223.95 | $583M | −1,253,538 | −$201M | |
| FTNT, Fortinet | Reduce −41.0% | 3,629,938 | $153.62 | $558M | −2,526,737 | +$55M | |
| TSM, Taiwan Semiconductor | New | 1,148,449 | $477.57 | $548M | +1,148,449 | +$548M | |
| IDXX, Idexx Laboratories | Reduce −30.4% | 1,019,887 | $526.44 | $537M | −445,899 | −$287M | |
| TXN, Texas Instruments | Reduce −31.4% | 1,799,182 | $298.07 | $536M | −823,942 | +$27M | |
| PM, Philip Morris International | Reduce −43.0% | 2,913,693 | $180.91 | $527M | −2,199,470 | −$318M | |
| NFLX, Netflix | New | 6,990,345 | $71.40 | $499M | +6,990,345 | +$499M | |
| GEV, GE Vernova | New | 409,835 | $1,175 | $481M | +409,835 | +$481M | |
| APP, AppLovin | New | 696,568 | $515.23 | $359M | +696,568 | +$359M | |
| TJX, TJX Companies | New | 2,272,592 | $151.50 | $344M | +2,272,592 | +$344M | |
| NXT, Nextpower | New | 2,856,092 | $119.14 | $340M | +2,856,092 | +$340M | |
| VEEV, Veeva Systems | New | 816,785 | $177.47 | $145M | +816,785 | +$145M | |
| YUM, Yum Brands | New | 556,107 | $159.86 | $89M | +556,107 | +$89M | |
| MSCI | Reduce −17.3% | 53,580 | $560.04 | $30M | −11,208 | −$4.9M | |
| MEDP, Medpace | Reduce −16.4% | 52,372 | $529.59 | $28M | −10,296 | −$2.4M | |
| NTNX, Nutanix | Reduce −6.8% | 538,281 | $50.96 | $27M | −39,111 | +$5.5M | |
| BMI, Badger Meter | Add +22.6% | 174,627 | $148.38 | $26M | +32,136 | +$4.2M | |
| CLX, Clorox | Add +5.5% | 271,318 | $95.44 | $26M | +14,101 | −$761K | |
| ROL, Rollins | Hold | 619,935 | $41.74 | $26M | — | — | |
| MANH, Manhattan Associates | Add +43.1% | 172,977 | $139.25 | $24M | +52,089 | +$8M | |
| NSSC, Napco Sec Technologies | Add +58.2% | 606,974 | $37.98 | $23M | +223,378 | +$7.9M | |
| FICO, Fair Isaac | New | 17,953 | $1,195 | $21M | +17,953 | +$21M | |
| SABR, Sabre | Hold | 9,013,783 | $2.09 | $19M | — | — | |
| IDCC, Interdigital | New | 60,324 | $283.13 | $17M | +60,324 | +$17M | |
| ORLY, O'Reilly Automotive | New | 162,691 | $92.09 | $15M | +162,691 | +$15M | |
| VRT, Vertiv | Reduce −54.1% | 41,893 | $334.82 | $14M | −49,361 | −$8.8M | |
| VRSN, VeriSign | Reduce −50.9% | 55,713 | $251.56 | $14M | −57,754 | −$14M | |
| ADMA, Adma Biologics | Hold | 1,649,493 | $8.37 | $14M | — | — | |
| DOCS, Doximity | Reduce −5.6% | 653,324 | $20.74 | $14M | −38,462 | −$2.6M | |
| PAYC, Paycom Software | Reduce −54.1% | 100,763 | $125.68 | $13M | −118,694 | −$14M |
Exits / last held
Gone since 2026 Q1, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| MTD, Mettler-Toledo | Exit | 0 | $1,261 | $717M | −568,516 | −$717M | |
| ZTS, Zoetis | Exit | 0 | $118.21 | $458M | −3,877,559 | −$458M | |
| OTIS, Otis Worldwide | Exit | 0 | $77.08 | $211M | −2,731,635 | −$211M | |
| Catalyst Pharmaceuticals | Exit | 0 | $24.76 | $21M | −844,887 | −$21M | |
| QLYS, Qualys | Exit | 0 | $87.85 | $20M | −226,077 | −$20M | |
| HD, Home Depot | Exit | 0 | $328.89 | $9.4M | −28,611 | −$9.4M |
Filings history
20 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 41 | $13.6B | +6.4% | 13F-HR | 8/14/2026 | 000156920526000012 |
| 2026 Q1 | 34 | $12.8B | −25.1% | 13F-HR | 5/15/2026 | 000156920526000005 |
| 2025 Q4 | 37 | $17.1B | −13.5% | 13F-HR | 2/17/2026 | 000156920526000002 |
| 2025 Q3 | 35 | $19.8B | −14.0% | 13F-HR | 11/14/2025 | 000156920525000004 |
| 2025 Q2 | 39 | $23B | +4.7% | 13F-HR | 8/14/2025 | 000180154725000008 |
| 2025 Q1 | 38 | $22B | −6.3% | 13F-HR | 5/15/2025 | 000152002325000003 |
| 2024 Q4 | 38 | $23.5B | −7.2% | 13F-HR | 2/14/2025 | 000152002325000002 |
| 2024 Q3 | 40 | $25.3B | +3.0% | 13F-HR | 11/14/2024 | 000152002324000040 |
| 2024 Q2 | 40 | $24.5B | −4.0% | 13F-HR | 8/14/2024 | 000152002324000030 |
| 2024 Q1 | 40 | $25.6B | +7.0% | 13F-HR | 5/15/2024 | 000152002324000020 |
| 2023 Q4 | 40 | $23.9B | +8.5% | 13F-HR | 2/14/2024 | 000152002324000014 |
| 2023 Q3 | 39 | $22B | −7.7% | 13F-HR | 11/14/2023 | 000152002323000012 |
| 2023 Q2 | 39 | $23.8B | +2.8% | 13F-HR | 8/14/2023 | 000152002323000011 |
| 2023 Q1 | 40 | $23.2B | +5.8% | 13F-HR | 5/15/2023 | 000152002323000010 |
| 2022 Q4 | 38 | $21.9B | +3.9% | 13F-HR | 2/14/2023 | 000152002323000001 |
| 2022 Q3 | 46 | $21.1B | −7.0% | 13F-HR | 11/14/2022 | 000152002322000010 |
| 2022 Q2 | 43 | $22.7B | −22.2% | 13F-HR | 8/15/2022 | 000152002322000009 |
| 2022 Q1 | 44 | $29.1B | −28.9% | 13F-HR | 5/16/2022 | 000152002322000006 |
| 2021 Q4 | 44 | $41B | +13.3% | 13F-HR | 2/14/2022 | 000186853722000005 |
| 2021 Q3 | 43 | $36.2B | — | 13F-HR | 11/12/2021 | 000152002321000007 |
About
Fundsmith LLP
20 processed 13Fs on this site, 2021 Q3 to 2026 Q2